Mesenchymal Stem/Stromal Cells and Their Derivates in Acute Diseases: Emergency in the Post-COVID-19 Times
The current coronavirus disease-19 (COVID-19) pandemic has strongly revived the pressing need to incorporate new therapeutic alternatives to deal with medical situations that result in a dramatic breakdown in the body’s normal homeostasis [...]
Main Authors: | Francisco J. Vizoso, Silvia Fernández-Francos, Noemi Eiro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/16/8395 |
Similar Items
-
Combating COVID-19 With Mesenchymal Stem/Stromal Cell Therapy: Promise and Challenges
by: Shihua H. Wang, et al.
Published: (2021-01-01) -
The Coronavirus Pandemic (SARS-CoV-2): New Problems Demand New Solutions, the Alternative of Mesenchymal (Stem) Stromal Cells
by: Noemi Eiro, et al.
Published: (2020-07-01) -
Extracellular vesicles derived from different sources of mesenchymal stem cells: therapeutic effects and translational potential
by: Jiaxin Cai, et al.
Published: (2020-05-01) -
Mesenchymal Stem Cell-Based Therapy as an Alternative to the Treatment of Acute Respiratory Distress Syndrome: Current Evidence and Future Perspectives
by: Silvia Fernández-Francos, et al.
Published: (2021-07-01) -
Mesenchymal stromal cells as a therapeutic intervention for COVID-19: a living systematic review and meta-analysis protocol
by: Aidan M. Kirkham, et al.
Published: (2021-09-01)